The current valuation score of Regeneron Pharmaceuticals Inc is 9.48, ranking 18 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 15.35, which is 94.29% below the recent high of 29.82 and 24.65% above the recent low of 11.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.